Literature DB >> 27238969

Structures of Human Peroxiredoxin 3 Suggest Self-Chaperoning Assembly that Maintains Catalytic State.

N Amy Yewdall1, Hariprasad Venugopal2, Ambroise Desfosses2, Vahid Abrishami3, Yuliana Yosaatmadja2, Mark B Hampton4, Juliet A Gerrard5, David C Goldstone6, Alok K Mitra7, Mazdak Radjainia8.   

Abstract

Peroxiredoxins are antioxidant proteins primarily responsible for detoxification of hydroperoxides in cells. On exposure to various cellular stresses, peroxiredoxins can acquire chaperone activity, manifested as quaternary reorganization into a high molecular weight (HMW) form. Acidification, for example, causes dodecameric rings of human peroxiredoxin 3 (HsPrx3) to stack into long helical filaments. In this work, a 4.1-Å resolution structure of low-pH-instigated helical filaments was elucidated, showing a locally unfolded active site and partially folded C terminus. A 2.8-Å crystal structure of HsPrx3 was determined at pH 8.5 under reducing conditions, wherein dodecameric rings are arranged as a short stack, with symmetry similar to low-pH filaments. In contrast to previous observations, the crystal structure displays both a fully folded active site and ordered C terminus, suggesting that the HsPrx3 HMW form maintains catalytic activity. We propose a new role for the HMW form as a self-chaperoning assembly maintaining HsPrx3 function under stress.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  X-Ray crystal structure; cryo-electron microscopy; high molecular weight form; molecular chaperone; peroxiredoxin

Mesh:

Substances:

Year:  2016        PMID: 27238969     DOI: 10.1016/j.str.2016.04.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  7 in total

Review 1.  Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Authors:  Evan A Elko; Brian Cunniff; David J Seward; Shi Biao Chia; Reem Aboushousha; Cheryl van de Wetering; Jos van der Velden; Allison Manuel; Arti Shukla; Nicholas H Heintz; Vikas Anathy; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

2.  X-ray crystallographic and high-speed AFM studies of peroxiredoxin 1 from Chlamydomonas reinhardtii.

Authors:  Ratana Charoenwattanasatien; Hideaki Tanaka; Karen Zinzius; Ana K Hochmal; Risa Mutoh; Daisuke Yamamoto; Michael Hippler; Genji Kurisu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-01-26       Impact factor: 1.056

3.  Self-assembly of toroidal proteins explored using native mass spectrometry.

Authors:  N Amy Yewdall; Timothy M Allison; F Grant Pearce; Carol V Robinson; Juliet A Gerrard
Journal:  Chem Sci       Date:  2018-06-18       Impact factor: 9.825

4.  Taking Advantage of the Morpheein Behavior of Peroxiredoxin in Bionanotechnology.

Authors:  Matteo Ardini; Andrea Bellelli; David L Williams; Luana Di Leandro; Francesco Giansanti; Annamaria Cimini; Rodolfo Ippoliti; Francesco Angelucci
Journal:  Bioconjug Chem       Date:  2021-01-07       Impact factor: 4.774

5.  Trypanosoma cruzi Mitochondrial Peroxiredoxin Promotes Infectivity in Macrophages and Attenuates Nifurtimox Toxicity.

Authors:  Gabriela Specker; Damián Estrada; Rafael Radi; Lucía Piacenza
Journal:  Front Cell Infect Microbiol       Date:  2022-02-04       Impact factor: 5.293

Review 6.  Peroxiredoxins in Cancer and Response to Radiation Therapies.

Authors:  Tom E Forshaw; Reetta Holmila; Kimberly J Nelson; Joshua E Lewis; Melissa L Kemp; Allen W Tsang; Leslie B Poole; W Todd Lowther; Cristina M Furdui
Journal:  Antioxidants (Basel)       Date:  2019-01-01

7.  Inactivity of Peptidase ClpP Causes Primary Accumulation of Mitochondrial Disaggregase ClpX with Its Interacting Nucleoid Proteins, and of mtDNA.

Authors:  Jana Key; Sylvia Torres-Odio; Nina C Bach; Suzana Gispert; Gabriele Koepf; Marina Reichlmeir; A Phillip West; Holger Prokisch; Peter Freisinger; William G Newman; Stavit Shalev; Stephan A Sieber; Ilka Wittig; Georg Auburger
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.